Efficacy and Safety of Ixekizumab for the Treatment of Plaque Psoriasis: Results through 108 Weeks Randomised, Phase III Clinical Trial (UNCOVER-3)
Keyword(s):
2017 ◽
Vol 137
(10)
◽
pp. S260
◽
Keyword(s):
2017 ◽
Vol 76
(6)
◽
pp. AB112
◽
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 37
(8)
◽
pp. 1726-1739
◽
Keyword(s):
2001 ◽
Vol 33
(7-8)
◽
pp. 3256-3258
◽
Keyword(s):